Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision tag Revision: v3.6.3 was added to the page. The previous Revision: v3.6.2 was removed, reflecting a minor version update.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page’s revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, representing a small version update in the page metadata.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page now indicates that no participants are being recruited and adds user-focused guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Interventions header formatting and the site revision label (from v3.5.5 to v3.6.0).SummaryDifference0.3%

- Check37 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This indicates a minor update to the page's content or metadata.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, signaling a minor version update in the content management system. This appears to be a behind-the-scenes change rather than a modification to user-visible content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe Taiwan location entry Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the study's list of sites, updating the geographic coverage in Taiwan.SummaryDifference0.0%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.